National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 265 cases where Age is under-19 and Vaccine is COVID19 and Manufacturer is PFIZER/BIONTECH and Patient Did Not Die and Hospitalized and Vaccination Date from '2021-07-01' to '2021-07-31'

Government Disclaimer on use of this data



Case Details

This is page 15 out of 27

Result pages: prev   6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24   next


VAERS ID: 1527897 (history)  
Form: Version 2.0  
Age: 17.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-06
Onset:2021-07-06
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-08-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE2625 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Anaphylactic shock, Balance disorder, Chest pain, Chills, Dizziness, Dyspnoea, Fatigue, Headache, Lip swelling, Malaise, Mouth swelling, Nausea, Pharyngeal erythema, Pharyngeal swelling
SMQs:, Anaphylactic reaction (narrow), Acute pancreatitis (broad), Angioedema (narrow), Anticholinergic syndrome (broad), Anaphylactic/anaphylactoid shock conditions (narrow), Oropharyngeal allergic conditions (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Vestibular disorders (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Food allergy ("tomato, bell pepper, pineapple, kiwi"); House dust mite allergy; Lactose intolerance (allergy: Lactose, pollen, tomato, bell pepper, pineapple, kiwi, house dust girl, shrimp); Pollen allergy; Shellfish allergy ("shrimp")
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: NLPFIZER INC202100932125

Write-up: chest burn; Throat turned red/erythema of throat; swelling of lips; swelling of throat; swelling of mouth; became short of breath, had a bad breath/short of breath, couldn''t breathe properly; Anaphylactic shock; Nausea; Headache; Fatigue; Cold shivers; Not feeling well; Dizziness; can''t stand upright for more than 4 minutes without falling; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority-WEB, regulatory authority number is NL-LRB-00614675. A 17-year-old female patient received BNT162B2 (COMIRNATY; lot number: FE2625 and expiration date: not reported), via an unspecified route of administration on 06Jul2021 (at the age of 17 years old) as dose 1, 0.3 ml single for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient had confounding factors and was allergic to lactose (intolerance), pollen and foods like tomato, bell pepper, pineapple and kiwi; shellfish (shrimp) and house dust mite. The patient didn''t had previous COVID-19 episode. The patient experienced chest burn; throat turned red/erythema of throat; swelling of lips, throat and mouth; short of breath and had a bad breath/short of breath and couldn''t breathe properly; anaphylactic shock; nausea; headache; fatigue; cold shivers; not feeling well; dizziness and can''t stand upright for more than 4 minutes without falling on 06Jul2021 following the administration of BNT162B2. The latency of these events was within one day after the vaccination. The events swelling of lips, mouth and throat; erythema of throat; dyspnea; chest discomfort and anaphylactic shock lead to hospitalization of patient in Jul2021 with the information reported as anaphylactic shock. The patient was treated with clemastine (TAVEGYL), epinephrine (EPIPEN), prednisolone and nebulization. The patient had been referred and tested by the allergist. The outcome of the patient was not recovered for the events dizziness, can''t stand upright for more than 4 minutes without falling, fatigue, headache and malaise 1 day after the onset and was recovering for the other events. Sender''s comment: Since the nature of the reported reactions does not imply seriousness according to one of the regulatory authority criteria, the reaction (dizziness) was considered as non-serious by the regulatory authority.


VAERS ID: 1527978 (history)  
Form: Version 2.0  
Age: 18.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-07-15
Onset:2021-07-18
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-08-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE6029 / 2 RA / -

Administered by: Other       Purchased by: ?
Symptoms: Myocarditis
SMQs:, Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Gilbert''s syndrome
Allergies:
Diagnostic Lab Data:
CDC Split Type: PLPFIZER INC202100961044

Write-up: Acute myocarditis; This is a spontaneous report from a contactable consumer (patient) received via regulatory authority. An 18-year-old male patient received second dose of bnt162b2 (COMIRNATY,Lot Number: FE6029), via an unspecified route of administration at the age of 18-year-old administered in arm right on 15Jul2021 at single dose for covid-19 immunisation. Medical history included gilbert''s syndrome. Prior to vaccination, the patient wasn''t diagnosed with COVID-19. The patient''s concomitant medications were not reported. The patient didn''t receive any other vaccines within 4 weeks prior to the COVID vaccine. There were no other medications the patient received within 2 weeks of vaccination. The patient previously received first dose of bnt162b2 (COMIRNATY, Lot number: FD4342) on 10Jun2021 at arm right for COVID-19 immunisation. The patient experienced acute myocarditis on 18Jul2021 09:00. The adverse event result in Emergency room/department or urgent care. The patient was hospitalized for 5 days. The events were serious for being hospitalization, disability, life threatening. Facility where the most recent COVID-19 vaccine was administered in Hospital. Since the vaccination, the patient hasn''t been tested for COVID-19. Treatment received for the adverse event included Diagnostics and treatment in a cardiology clinic. The outcome of event was recovering.


VAERS ID: 1533800 (history)  
Form: Version 2.0  
Age: 18.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-09
Onset:2021-07-09
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-08-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FC5029 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Anti-aquaporin-4 antibody, Autoantibody test, CSF test, Diplopia, Dyschromatopsia, Magnetic resonance imaging head, Neurological examination, Optic neuritis, Vision blurred, Visual evoked potentials, Visual impairment
SMQs:, Anticholinergic syndrome (broad), Glaucoma (broad), Optic nerve disorders (narrow), Demyelination (narrow), Lens disorders (broad), Retinal disorders (broad), Ocular infections (broad), Ocular motility disorders (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: NEXPLANON
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 202107; Test Name: Anti-aquaporin-4 antibody; Test Result: Negative ; Test Date: 202107; Test Name: Autoantibody NOS; Result Unstructured Data: Test Result:MOG antibodies negative; Comments: MOG antibodies negative from serum and spinal fluid; Test Date: 202107; Test Name: CSF test; Result Unstructured Data: Test Result:normal findings; Comments: Spinal fluid with normal findings; Test Date: 202107; Test Name: MRI brain; Result Unstructured Data: Test Result:optic neuritis right side; Comments: Mild degree of optic neuritis right side accompanied by discrete inflammatory fat tissue retrobulbar, also two small white matter lesions left side high frontal, that could indicate a possible early finding of multiple sclerosis.; Test Date: 202107; Test Name: Neurological examination; Result Unstructured Data: Test Result:No other neurological disturbances; Comments: No other neurological disturbances; Test Date: 202107; Test Name: Visual evoked potentials; Result Unstructured Data: Test Result:negative findings; Comments: VEP with negative findings
CDC Split Type: NOPFIZER INC202100940043

Write-up: COLOR VISION CHANGE; VISION DECREASED; BLURRED VISION; DIPLOPIA RIGHT EYE; optic neuritis on the right side; This is a spontaneous report from a contactable physician downloaded from the WEB, regulatory authority number NO-NOMAADVRE-FHI-2021-Uyma7w. An 18-year-old female patient received bnt162b2 (COMIRNATY), intramuscular, administered in arm left on 09Jul2021 12:00 (Batch/Lot Number: FC5029) (at age 18-years-old) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included etonogestrel (NEXPLANON) taken for contraception from 01Jul2019 to an unspecified stop date. The patient experienced color vision change, vision decreased, blurred vision, diplopia right eye and optic neuritis on the right side on 09Jul2021 which caused hospitalization on 10Jul2021. Clinical course was as follows: The patient received the first dose of Comirnaty (batch no FC5029) 09Jul2021. She was hospitalized the next day due to diplopia right eye, also blurred vision, disturbed colour vision and reduced vision. She was examined by ophthalmologist and neurologist without findings of any other neurological disturbances. VEP with negative findings. MR caput: mild degree of optic neuritis right side accompanied by discrete inflammatory fat tissue retrobulbar. Also, two small white matter lesions left side high frontal, that could indicate a possible early finding of multiple sclerosis. She received treatment with 5 g Solu-Medrol (methylprednisolone) with little/no improvement. Spinal fluid with normal findings, aquaporin-4 antibodies and MOG antibodies negative from serum and spinal fluid. The patient still has the same symptoms (she states to have little/no vision of the right side). New examination planned with VEP and outpatient ophthalmologist examination. The reactions are Serious and Not recovered/not resolved, at the reporting date, 19Jul2021, ten days after vaccination. The causality assessment is Possible. Reporter Comment: The reporter has been asked to forward more information regarding this case. Sender Comment: This is an interesting message, and we would like a little more information about the incident if possible. Does the patient have any history of neurological disease or eye disease? Is there such a disease in the family (especially interesting with information about any cases of MS in the family). Did the symptoms occur acutely after the vaccine or did she have a tendency to have visual disturbances even before she received the vaccine? We are also interested in further processes and findings from examinations that are performed, as well as any assessments from an ophthalmologist / neurologist about the possibility of causality with the vaccine. Assessed the causal relationship between bnt162b2 (COMIRNATY) and all the reported events as Possible. No follow-up attempts possible. No further information expected.; Reporter''s Comments:: The reporter has been asked to forward more information regarding this case.; Sender''s Comments: Linked Report(s) : NO-PFIZER INC-202100968070 Same reporter, same patient, different product, different events


VAERS ID: 1533869 (history)  
Form: Version 2.0  
Age: 18.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-07-27
Onset:2021-07-27
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-08-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Blood pressure decreased, Feeling hot, Pain in extremity, Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: SEPFIZER INC202100967363

Write-up: fall in blood pressure and fainted; fall in blood pressure and fainted; pain in arm; feeling warm; This is a spontaneous report from a contactable consumer reporting for her son. A 18-years-old male patient received bnt162b2 (COMIRNATY, solution for injection, Lot number was not reported), dose 1 via an unspecified route of administration on 27Jul2021 (at a age of 18-years-old) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was stated that once patient received syringe of vaccine he had fall in blood pressure and fainted on 27Jul2021, pain in arm, feeling warm on 28Jul2021. He was picked up by the ambulance and after controls at the hospital the doctor said that it was a blood pressure drop and not an allergic reaction. The outcome of the event fall in blood pressure and fainted was recovered in 2021. The outcome of pain in arm and feeling warm was not recovered. The lot number for the vaccine, Comirnaty, was not provided and will be requested during follow up.


VAERS ID: 1538040 (history)  
Form: Version 2.0  
Age: 18.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-07-13
Onset:2021-07-13
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-08-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE3065 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Bradycardia, Consciousness fluctuating, Heart rate, Seizure, Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Arrhythmia related investigations, signs and symptoms (broad), Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210713; Test Name: Heart rate; Result Unstructured Data: Test Result:37; Comments: Bradycardia with heart rate of 37
CDC Split Type: FIPFIZER INC202100954768

Write-up: Convulsion; Bradycardia; Syncope; Consciousness fluctuating; This is a spontaneous report received from a contactable other hcp downloaded from the regulatory authority-WEB, regulatory authority number FI-FIMEA-20213662. A 18-years-old male patient received first dose of bnt162b2 (COMIRNATY, Formulation: Solution for injection, Lot number: FE3065), via an intramuscular route of administration on 13Jul2021 (at the age of 18-years-old) as dose 1, 0.3ml single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient fainted immediately after the vaccination. After fainting, the patient was feeling unstable and also had seizures in few second cycles. Bradycardia with heart rate of 37, syncope, consciousness fluctuating. No underlying conditions, allergies or previous reactions to vaccinations. First vaccination dose. Taken to hospital by ambulance for further treatment. The events assessed as serious (hospitalisation). The patient underwent lab tests and procedures which included heart rate: 37 on 13Jul2021 (bradycardia with heart rate of 37). The outcome of the events was reported as unknown. No follow-up attempts possible. No further information expected.


VAERS ID: 1538091 (history)  
Form: Version 2.0  
Age: 18.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-07-12
Onset:2021-07-12
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-08-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FE7010 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Chills, Discomfort, Dyspnoea, Loss of consciousness, Malaise
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC202100949330

Write-up: Feeling sick; discomfort with loss of consciousness; loss of consciousness; breathing difficulties/shortness of breath; chills; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB, Regulatory authority report number FR-AFSSAPS-BR20212775. An 18-year-old male patient received BNT162B2 (COMIRNATY), intramuscular in left arm on 12Jul2021 (Lot Number: FE7010, unknown expiration; at the age of 18 years old) as dose 1, single for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 12Jul2021, 5 minutes after the injection, the patient experienced feeling sick, discomfort with loss of consciousness, breathing difficulties/shortness of breath, and chills. The patient was healing without sequelae. The patient recovered from the events in Jul2021. The events were assessed as serious (hospitalization). No follow-up attempts are possible; information about batch number was already obtained.


VAERS ID: 1538205 (history)  
Form: Version 2.0  
Age: 14.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-10
Onset:2021-07-13
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-08-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / UNK - / OT
UNK: VACCINE NOT SPECIFIED (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Blood pressure measurement, Body temperature, Dyskinesia, Headache, Heart rate, Malaise, Pallor, Pyrexia, Staring, Tremor, Urine analysis
SMQs:, Neuroleptic malignant syndrome (narrow), Anticholinergic syndrome (broad), Dyskinesia (narrow), Parkinson-like events (broad), Noninfectious encephalopathy/delirium (broad), Hypotonic-hyporesponsive episode (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Vaso vagal attack
Allergies:
Diagnostic Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:141/86; Test Name: body temperature; Result Unstructured Data: Test Result:37.1 Centigrade; Test Name: body temperature; Result Unstructured Data: Test Result:38.2 Centigrade; Test Name: heart rate; Result Unstructured Data: Test Result:113 bpm; Test Name: urine strip test; Result Unstructured Data: Test Result:Acetonuria +++, proteinuria +, no nitrite; Comments: no leucocytes
CDC Split Type: FRPFIZER INC202100949155

Write-up: unusual jerking of hands and arms; Shakiness/tremors; febrile at 38.2 ?C, malaise with pallor and staring; febrile at 38.2 ?C, malaise with pallor and staring; febrile at 38.2 ?C, malaise with pallor and staring/not feeling well; febrile at 38.2 ?C, malaise with pallor and staring; Headaches; This is a spontaneous report from a contactable physician downloaded from the WEB, regulatory authority number FR-AFSSAPS-TS20213118. A 14-year-old female patient received BNT162B2 (COMIRNATY), intramuscular on 13Jul2021 (Batch/Lot Number: Unknown) as dose number unknown, single (at the age of 14 years old) for COVID-19 immunisation; ciprofloxacine [ciprofloxacin] (CIPROFLOXACINE [CIPROFLOXACIN]), oral from 10Jul2021 (Batch/Lot number was not reported) to 14Jul2021, at unspecified dose for urinary infection. Medical history included vasovagal syndrome from Jun2021 to an unknown date. The patient''s concomitant medications were not reported. The patient previously took MONURIL at the end of Jun2021 taken for a first episode of urinary infection (due to persistent functional urinary signs and lower back pain). It was reported that second dose of COMIRNATY on 13Jul2021, the patient experienced headaches during the night. On 14Jul2021 (day after the vaccine), while watching TV, appearance of tremors (also reported as shakiness) of the left arm, then of both legs, then of the right arm then of the tongue. No loss of consciousness, no fall, no trauma. Accident and emergency (A&E) consultation. Normal neurological examination on admission. Regression of tremors upon arrival in cubicle, not seen by carers. Temperature 37.1, heart rate 113 bpm, blood pressure 141/86 mmHg. Ciprofloxacin was discontinued. In the evening at the A&E, febrile at 38.2 C, malaise with pallor and staring, no postictal confusion, rapid return to the previous state. Urine strip test: Acetonuria +++, proteinuria +, no nitrite, no leucocytes. At 11:30 p.m., is not feeling well, unusual jerking of hands and arms, according to the mother. Meal offer: Could not hold its tray. When the carers arrived, she holds her tray, hand clenched. The patient was admitted to hospital for monitoring. No recurrence of tremors. Returned home on 16Jul2021. In summary, episode of tremors of the 4 limbs at rest, 1 day after dose 2 of COMIRNATY and 4 days of ciprofloxacin in a 14 year old female patient, without particular medical history. The patient was hospitalized for shakiness/tremors, febrile at 38.2 ?c, malaise with pallor, staring and unusual jerking of hands and arms from 14Jul2021 to 16Jul2021. The patient underwent lab tests and procedures on unspecified date which included blood pressure: 141/86, body temperature: 37.1 centigrade and 38.2 centigrade, heart rate: 113 bpm, urine strip test: acetonuria +++, proteinuria +, no nitrite, no leucocytes. The action taken in response to the events for ciprofloxacine [ciprofloxacin] was permanently withdrawn on 14Jul2021. The outcome of the event headaches was unknown while the other events was recovered on 14Jul2021 (as reported). No follow-up activities are possible. No further information is expected. Batch/LOT number cannot be obtained.


VAERS ID: 1539063 (history)  
Form: Version 2.0  
Age: 14.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-07-05
Onset:2021-07-05
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-08-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Biopsy bone marrow, Blood pressure decreased, Blood pressure measurement, Cardiac arrest, Computerised tomogram, Loss of consciousness, Lymphoma, Pericardial effusion, Respiratory arrest
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypersensitivity (broad), Malignant lymphomas (narrow), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Haematological malignant tumours (narrow), Dehydration (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Common cold
Allergies:
Diagnostic Lab Data: Test Name: bone marrow test; Test Result: Negative ; Test Date: 20210723; Test Name: blood pressure; Result Unstructured Data: Test Result:dropped; Test Date: 202107; Test Name: Computed tomography; Result Unstructured Data: Test Result:Lymphoma
CDC Split Type: MNPFIZER INC202100960418

Write-up: Lymphoma; an emergency operation to remove about 500 grams of fluid from the pericardium; sudden cessation of breathing during anesthesia before the operation; the heart stopped twice; the blood pressure dropped; lost consciousness for 10 hours; This is a spontaneous report from a contactable consumer (the patient''s farther). A 14-year-old male patient received bnt162b2 (BNT162B2), via an unspecified route of administration on 05Jul2021 (at the age of 14 years old, Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included common cold from an unknown date. The patient''s concomitant medications were not reported. The reporter stated the patient was in critical condition in the hospital today (27Jul2021). They believed that this condition was caused by the effects of the Pfizer vaccine. Until the age of 14, the patient did not have any other illnesses other than the common cold, he was a healthy child and did not have any chronic diseases. After the vaccination on 05Jul2021, he developed a mild fever and cough, on 11Jul2021, the symptoms worsened. He was taken to the hospital on the night of 22Jul2021, and on the morning of 23Jul2021, he underwent an emergency operation to remove about 500 grams of fluid from the pericardium (the membrane enclosing the heart). He also had a sudden cessation of breathing during anesthesia before the operation. During the operation, the heart stopped twice, the blood pressure dropped, and he lost consciousness for 10 hours. Computed tomography (CT) scan in Jul2021 revealed a large tumour about 150 mm in the chest area. (hospital''s Computed tomography (CT)diagnostic document is attached). The result of the computer diagnosis was Lymphoma. The reporter stated they did not agree with this CT diagnostic. No one in their family suffered from this disease. The bone marrow test was negative. They believe that it was impossible for their child who has not had any disease since he was born to have a 150mm large tumour. Due to the effects of the vaccine, their son, who was healthy, has had many life-threatening complications since he was vaccinated, and today his life was at great risk. The outcome of the event Lymphoma was not resolved. The outcome of lost consciousness was resolved in Jul2021 and for other events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1541676 (history)  
Form: Version 2.0  
Age: 12.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-07-08
Onset:2021-07-08
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-08-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FO4555 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Blood pressure measurement, Capillary nail refill test, Heart rate, Mydriasis, Peripheral coldness, Sensation of foreign body, Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Celiac disease
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210708; Test Name: Blood pressure; Result Unstructured Data: Test Result:140/80 mmHg; Comments: at 15:30, 5 minutes after vaccination; Test Date: 20210708; Test Name: Blood pressure; Result Unstructured Data: Test Result:114/80 mmHg; Test Date: 20210708; Test Name: Capillary nail refill test; Result Unstructured Data: Test Result:$g3 seconds; Test Date: 20210708; Test Name: Pulse rate; Result Unstructured Data: Test Result:98; Comments: /min, at 15:30, 5 minutes after vaccination; Test Date: 20210708; Test Name: Pulse rate; Result Unstructured Data: Test Result:55; Comments: /min, at 15: 45, after 10 minutes
CDC Split Type: HUPFIZER INC202100967490

Write-up: Lump feeling in throat; Collapse; pupils were dilated; peripheries were cold; This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB, regulatory authority number HU-OGYI-651721. A 12-year-old male patient received bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: FO4555) via intramuscularly, administered in arm left on 08Jul2021 at 15:25 (at the age of 12-year-old) as dose 1, 0.3ml single for COVID-19 immunisation. Medical history included ongoing Celiac disease. The patient concomitant medications were not reported. On 08Jul2021 at 15:30, 5 minutes after vaccination, the patient experienced collapse and on 08Jul2021 at 15:45, patient experienced peripheries were cold, lump feeling in throat and pupils were dilated. Patient blood pressure was 140/80 mmHg, pulse rate was 98/min. The patient condition settled in 10 minutes, then after 10 minutes, he had lump feeling in his throat, his eyes rolled back, pulse was 55/min, his peripheries were cold, capillary refill time was over 3 seconds. Breathing and heart sounds were well-toned and rhythmic, the pupils were dilated but responded adequately to light. The patient was transported to the hospital, from where he was discharged in good general condition on 10Jul2021 (no medical records were provided). At 15:55, he received 40 mg of Solu-Medrol (methylprednisolone) intravenously, at which point an ambulance was called. After administration of Solu-Medol, the lump feeling in his throat resolved, but his blood pressure and heart rate fluctuated. The patient was hospitalized for all events from 08Jul2021 to 10Jul2021. The patient underwent lab tests and procedures which included Blood pressure: 140/80 (at 15:30, 5 minutes after vaccination) and 114/80 mmhg, Capillary nail refill test: $g3 seconds and Pulse rate: 98 (/min, at 15:30, 5 minutes after vaccination) and 55 (/min, at 15: 45, after 10 minutes) on 08Jul2021. Therapeutic measures were taken as a result of both event and treatment included with at 15:55, 40 mg of Solu-Medrol (methylprednisolone) intravenously and paramedics administered vitamine B6, Suprastin (chloropyramine) and Emetron (ondansetron). The outcome of the events was resolved on 08Jul2021. Sender''s comments: Syncope and lump feeling in throat occurred after Comirnaty vaccination. Time to onset was 5-20 minutes. The causal relationship between the events and Comirnaty is considered possible. The case is serious due to hospitalization. No follow-up attempts possible. No further information expected.


VAERS ID: 1541965 (history)  
Form: Version 2.0  
Age: 2.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-07-08
Onset:2021-07-08
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-08-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FF0680 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Coccydynia, Diarrhoea, Electrocardiogram, Exposure via breast milk, Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Pseudomembranous colitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Neonatal exposures via breast milk (narrow), Hypotonic-hyporesponsive episode (broad), Noninfectious diarrhoea (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: AZALIA
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: ECG; Result Unstructured Data: Test Result:Baseline activity at 6-7 Hz, posterior, symmetric,; Comments: baseline activity at 6-7 Hz, posterior, symmetric, reactive, regular and broad. No spikes, abrupt waves or other focal or generalized paroxysms were identified. No specific ELI changes. No epileptic seizures or behavioral changes were observed. Exam without recording of epileptiform activity or other changes.
CDC Split Type: PTPFIZER INC202100949263

Write-up: Fainting of the 2-year-old daughter who breastfeeds; Intestinal disarrangement of the 2-year-old daughter who breastfeeds/pooped several times; got a sore tail; 2-year-old daughter who breastfeeds; This is a spontaneous report from a contactable consumer (patient''s mother) downloaded from a regulatory authority-WEB, regulatory authority number PT-INFARMED-R202107-3352. This consumer reported events for herself and her daughter. This is the report for the child. A 2-year-old female patient received bnt162b2 (COMIRNATY), dose 1 transmammary, at age 2 years, on 08Jul2021 (Batch/Lot Number: FF0680) as DOSE 1, 0.3 ML SINGLE for COVID-19 immunisation. The patient''s medical history was not reported. Concomitant medications of the mother included desogestrel (AZALIA) taken for an unspecified indication, start and stop date were not reported. There is no reference to taking any medication. Previous reactions to other drugs are not known. On the day the mother took the vaccine, she had the sensation that she felt the vaccine spread through her body. The next day (09Jul2021), mother had some dizziness and when she woke up, she had the feeling that she couldn''t feel her legs. The patient, her daughter (2 years old) pooped several times, got a sore tail and after 4 days, on 13Jul2021, fainted. The adverse drug reaction (ADR) intestinal disarrangement started 1 day after administration of the suspected drug, with an approximate duration of 24 hours. Fainting ADR started 5 days after administration of the suspected drug, lasting approximately 3 minutes. Fainting ADR caused hospital observation on Jul2021. Specific treatment of reaction unknown. The patient underwent lab tests and procedures that includes EEG (Electroencephalogram) performed on an unspecified date with baseline activity at 6-7 Hz, posterior, symmetric, reactive, regular and broad. No spikes, abrupt waves or other focal or generalized paroxysms were identified. No specific ELI changes. No epileptic seizures or behavioral changes were observed. Exam without recording of epileptiform activity or other changes. The outcome of the event fainting was recovered on 13Jul2021 after 3 mins and for ''Intestinal disarrangement of the 2-year-old daughter who breastfeeds/pooped several times'', it was recovered on 09Jul2021 for 1 day; while for the other event, it was unknown. Reporter''s Comment: Concomitant Medication-Azalia Did Medication Error Occur?-No Other Information-On the day I took the vaccine, I had the sensation that I felt the vaccine spread through my body. The next day I had some dizziness and when I woke up I had the feeling that I couldn''t feel my legs. My daughter (2 years old) pooped several times, got a sore tail and after 4 days fainted. No follow-up attempts are possible. No further information is expected.; Reporter''s Comments: Concomitant Medication-Azalia Did Medication Error Occur?-No Other Information-On the day I took the vaccine, I had the sensation that I felt the vaccine spread through my body. The next day I had some dizziness and when I woke up I had the feeling that I couldn''t feel my legs. My daughter (2 years old) pooped several times, got a sore tail and after 4 days fainted.; Sender''s Comments: Linked Report(s) : PT-PFIZER INC-202100969667 mother case


Result pages: prev   6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=15&VAX=COVID19&VAXMAN=PFIZER/BIONTECH&HOSPITAL=Yes&DIED=No&WhichAge=range&LOWAGE=(0)&HIGHAGE=(19)&VAX_YEAR_LOW=2021&VAX_MONTH_LOW=07&VAX_YEAR_HIGH=2021&VAX_MONTH_HIGH=07


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166